购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Spebrutinib

Rating icon 很棒
产品编号 T2603Cas号 1202757-89-8
别名 LMK-435, CC-292, AVL-292

Spebrutinib (LMK-435) 是一种共价的、高效的、选择性的、具有口服活性的Btk 抑制剂 (IC50:0.5 nM)。

Spebrutinib

Spebrutinib

Rating icon 很棒
纯度: 100%
产品编号 T2603 别名 LMK-435, CC-292, AVL-292Cas号 1202757-89-8

Spebrutinib (LMK-435) 是一种共价的、高效的、选择性的、具有口服活性的Btk 抑制剂 (IC50:0.5 nM)。

规格价格库存数量
5 mg¥ 498现货
10 mg¥ 747现货
50 mg¥ 2,161现货
100 mg¥ 3,717现货
1 mL x 10 mM (in DMSO)¥ 548现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"Spebrutinib"的相关化合物库

选择批次:
纯度:97.02%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
靶点活性
BTK:<0.5 nM
体外活性
口服3-30 mg/kg AVL-292抑制胶原蛋白诱导的小鼠关节炎模型中的炎症临床症状,包括关节和爪肿胀以及感染爪的可见发红的减少.
体内活性
AVL-292通过抑制BTK的活性,进一步抑制B细胞的增殖,EC50为3 nM。AVL-29对在Ramos细胞中的BTK产生抑制作用,EC50为8 nM,具有剂量依赖性,并且抑制了下游的BCR通路。
激酶实验
Procedures for BTK OMNIA Assay: The Omnia continuous read assay is performed essentially as described by the vendor. The assay conditions are: 40 μM ATP (1X KMATP), 10 μM Y5-Sox, and 10 nM BTK enzyme. Briefly, a substrate mix containing 1.13X ATP and the Y5 Sox substrate is first prepared in 1X Omnia Kinase Reaction Buffer (KRB) consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM?β-glycerophosphate, 5% glycerol, and 0.2 mM DTT. For IC50 measurements, 5 μL of enzyme are incubated with serially diluted (3-fold) compounds prepared in 50% DMSO in a Corning (#3574) 384-well, white, non-binding surface microtiter plate at 25°C for 30 min. Kinase reactions are started with the addition of 45 μL of the ATP/Y5 substrate mix and monitored at λex360/λem485 in a Synergy 4 plate reader for 60 minutes. Progress curves from each well are examined for linear reaction kinetics and fit statistics. Initial velocity from each reaction is determined from the slope of a plot of relative fluorescence units versus time and then plotted against inhibitor concentration to estimate IC50 using the Response, Variable Slope model in GraphPad Prism from GraphPad Software.
细胞实验
A suspension of resting purified na?ve human B cells isolated by negative selection in RPMI is prepared at 0.4–0.5 × 106 cells/ml. Cells are mixed together with α-human IgM (final concentration of 5 μg/ml in each well) and vehicle (dimethyl sulfoxide) or AVL-292 (final concentrations of 0.01, 0.1, 1.0, 10.0, 100.0, or 1000 nM per well) and seeded in a 96-well plate. Cells are incubated for 56 hours in a humidified incubator maintained at 37°C and 5% CO2. 3H-Thymidine is added (final concentration of 1 μCi in each well) and cells are incubated overnight, harvested, and measured for 3H incorporation. Experiments are performed in triplicate.(Only for Reference)
别名LMK-435, CC-292, AVL-292
化学信息
分子量423.44
分子式C22H22FN5O3
CAS No.1202757-89-8
SmilesCOCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1
密度1.322 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 79 mg/mL (186.6 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.3616 mL11.8080 mL23.6161 mL118.0805 mL
5 mM0.4723 mL2.3616 mL4.7232 mL23.6161 mL
10 mM0.2362 mL1.1808 mL2.3616 mL11.8080 mL
20 mM0.1181 mL0.5904 mL1.1808 mL5.9040 mL
50 mM0.0472 mL0.2362 mL0.4723 mL2.3616 mL
100 mM0.0236 mL0.1181 mL0.2362 mL1.1808 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Spebrutinib | purchase Spebrutinib | Spebrutinib cost | order Spebrutinib | Spebrutinib chemical structure | Spebrutinib in vivo | Spebrutinib in vitro | Spebrutinib formula | Spebrutinib molecular weight